Today March 28 the Swedish market close at 13.00. Danish and Norweigan markets is closed.

ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales go through wholesale distributors and pharmacies. The products are used for the treatment of multiple sclerosis, chronic pain, and chemotherapy. ODI Pharma operates in the European market and is headquartered in Stockholm.

Quotes for ODI Pharma AB

Right Now

+/-
0.15
%
2,86%
Latest
5.4
High
5.5
Low
5.3
Volume
1 070
Turnover (SEK)
5 684
Market Value (MSEK)
82,2
Time (Latest trade)
2024-03-28 09:41

Board

CEO

  • Derek Simmross

Chairperson of the Board

  • Volker Wiederrich

Board

  • Derek Simmross
  • Gösta Lidén
  • Karina Kilinski

Videos

Largest Owners

Name Capital % Votes % Date
Volker Wiederrich 39,79 39,79 2023-12-27
Derek Simmross 25,95 25,95 2023-12-27
Niclas Kappelin 25,58 25,58 2023-12-27
Tomi Kalevi Heikkinen 0,33 0,33 2023-12-27
Kyösti Antero Tuuli 0,33 0,33 2023-12-27
Siv Merethe Skorpen 0,32 0,32 2023-12-27
Erlend Skorpen 0,32 0,32 2023-12-27
Irina Bontch-Osmolovskaia Norström 0,27 0,27 2023-12-27
Per Herseth 0,25 0,25 2023-12-27
Nordnet Pensionsförsäkring 0,18 0,18 2023-12-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-05-30 Delårsrapport 2024-Q3

  • 2024-08-29 Bokslutskommuniké 2024